Metropolis Healthcare - Inorganic Foray into Non-Core Markets; Scalability Key Monitorable
MHL announced its acquisition of Core Diagnostics—an oncology focused diagnostics chain with majority of its revenue derived from North/East India—...
222 Views
Metropolis Healthcare: Core Diagnostic M&A to Strengthen Speciality Portfolio.
Metropolis signed a definite agreement to acquire a 100% stake in Core Diagnostics. This acquisition will strengthen its advanced cancer testing...
210 Views
Metropolis Healthcare - Tier 3 Expansion and Wellness Portfolio to Drive Revenue Growth
MHL’s Q2FY25 print was in line with our estimates, with revenues growing 13% YoY, driven by B2C revenues improving 21% YoY.
81 Views
HSIE Results Daily: Shree Cement, Aurobindo Pharma, Gujarat State Petronet
During Q2FY25, Shree volume declined 7% YoY as it focused on trade sales while non-trade demand was weak. Cement NSR fell only 0.4% QoQ, lower vs...
193 Views
Pharma and Healthcare (Q2FY25E Results Preview): Steady Q2, Revlimid to Normalise
The India Pharma & Healthcare sector is expected to maintain its growth momentum in Q2FY25E. We project sales/EBITDA growth of 11%/15% YoY for our...
213 Views